News
June 2023
-
Cancer CareJune 01, 2023Calling all citizen scientists who use wells!
Own a well and wonder if the water quality could pose a cancer risk? You may want to enroll in a new cancer center study.
Read More
May 2023
-
ResearchMay 25, 2023New treatment for recurrence of C. difficile infection approved by FDA
The FDA approved VOWST to prevent recurrence of C. difficile infection. The approval is based on a trial in which UC Davis Health’s Stuart Cohen served as principal investigator.
Read More -
Cancer CareMay 24, 2023Advancing health equity in breast cancer care
Two $750,000 research grants awarded by Gilead Sciences will help the cancer center launch innovative outreach programs aimed at improving breast cancer health equity.
Read More -
MIND InstituteMay 19, 2023New study finds common autism screening tool is effective but has limitations
A UC Davis MIND Institute analysis of 13 studies finds that a common autism screening tool is useful, but a clinician’s judgment is still needed.
Read More -
Cancer CareMay 19, 2023Study aims to understand lung cancer in non-smoking Asian American women
A Bay Area study of non-smoking Asian American women with lung cancer has expanded to include Sacramento. The study is the first and largest of its kind.
Read More -
Internal MedicineMay 16, 2023UC Davis Health launches new Invasive E. coli disease vaccine trial
A clinical study by researchers will evaluate a vaccine for preventing Invasive E. coli disease in older adults with a history of urinary tract infections.
Read More -
Betty Irene Moore School of NursingMay 15, 2023UC Davis nursing school announces 2023 Betty Irene Moore Fellows
The Betty Irene Moore Fellowship for Nurse Leaders and Innovators has announced its largest cohort ever: 16 nurse scientists from around the U.S.
Read More -
Cancer CareMay 11, 2023Cancer center launches new science hub called WeCARE
The Women’s Cancer Care and Research Program is a new initiative to drive community-informed science that advances prevention and treatment of breast and gynecologic cancers.
Read More -
Cancer CareMay 08, 2023Strong link between bone biomarkers and prostate cancer survival
Bone disease in prostate cancer patients can be devastating, but new research led by UC Davis Comprehensive Cancer Center aims to improve the odds.
Read More -
ResearchMay 05, 2023
Aggie Square hits milestone with topping off ceremony
Nearly 200 trade partners and community guests celebrated the “topping off” of Aggie Square, signifying that the first phase of the transformational project nears completion.
Read More -
Heart and VascularMay 04, 2023How does stress from everyday life impact heart health?
UC Davis Health scientists have received a grant from the American Heart Association to study the effects of chronic stress on cardiovascular disease in underserved populations.
Read More
April 2023
-
ResearchApril 27, 2023National Heart, Lung and Blood Institute awards cardiology professor $7.7 million
Ye Chen-Izu has received a national award to support her research into how the heart functions as a smart pump and how mechanical stress leads to heart diseases.
Read More -
Clinical ScienceApril 25, 2023Can brown fat cells combat obesity?
Endocrinology researchers were awarded a grant from the NIH to investigate the role of two newly identified molecules that control heat production from fat tissues to combat obesity complications.
Read More -
AgingApril 21, 2023Tool to support long-distance caregivers gets NIH funding boost
UC Davis Health researcher receives new funding for an interactive platform she developed that offers a real-time view of older adults living alone.
Read More -
ResearchApril 20, 2023The Hartwell Foundation selects two UC Davis faculty for Individual Biomedical Research Awards
Roy Ben-Shalom and Geoanna Bautista were selected for the 2022 Hartwell Individual Biomedical Research Awards. These fund early-stage, innovative and cutting-edge biomedical research benefiting children in the U.S.
Read More -
ResearchApril 19, 2023Clinical trial begins using CAR T cells to potentially cure HIV
UC Davis Health researchers have dosed the second participant in their clinical trial looking to identify a potential cure for HIV utilizing CART-cell therapy.
Read More -
ResearchApril 18, 2023
UC Davis Health receives 2023 Top Ten Clinical Research Achievement Award
Chair of Physical Medicine and Rehabilitation Craig McDonald was honored with a 2023 Top Ten Clinical Research Achievement Award, in recognition of his remarkable work on Duchenne muscular dystrophy.
Read More -
ResearchApril 17, 2023Researchers discover how some brain cells transfer material to neurons in mice
A UC Davis study is the first to report on a material transfer mechanism from cells known as oligodendrocytes to neurons in the brain of a mouse model.
Read More -
Neurological HealthApril 14, 2023UC Davis team identifies genes that can help improve stroke diagnosis and treatment
A new study suggests that the behavior of certain genes during a stroke can help guide providers to more specific treatment options for improved outcomes.
Read More -
Cancer CareApril 13, 2023Cancer center lands prestigious NCI grant to advance immunotherapy in head and neck cancer
Pioneering research into effective immunotherapy treatment for head and neck cancer comes to UC Davis Comprehensive Cancer Center thanks to high-level federal funding.
Read More -
ResearchApril 10, 2023Applied Public Health Research Day connects UC Davis students and scholars
At the recent Applied Public Health Research Day, UC Davis students showcased their research, got presentation experience, and benefitted from the feedback of experienced researchers and faculty.
Read More -
Neurological HealthApril 07, 2023High blood pressure in your 30s associated with worse brain health in your 70s
A new study suggests treating high blood pressure in young and middle-aged adults may help prevent dementia and Alzheimer’s in later life, especially for men.
Read More
March 2023
-
ResearchMarch 23, 2023New treatment for invasive fungal infection candidiasis approved by FDA
The FDA has approved a new treatment for candidiasis called rezafungin for injection. The approval is based on a clinical trial in which George Thompson served as principal investigator.
Read More -
RehabilitationMarch 10, 2023International study on Duchenne muscular dystrophy provides foundation for future research
An international study on Duchenne Muscular Dystrophy led by UC Davis Health will build a robust database on the progression of the disorder.
Read More -
School of MedicineMarch 09, 2023Medical students display innovative research at Poster Day
A wide range of innovative research by medical students was on display at this year’s Poster Day, as School of Medicine continues its mission of improving health through innovative research.
Read More -
MIND InstituteMarch 03, 2023UC Davis study uncovers age-related brain differences in autistic individuals
Differences in genes involved in inflammation, immunity response and neural transmissions begin in childhood and evolve across the lifespan in brains of people with autism, a UC Davis MIND Institute has found.
Read More -
ResearchMarch 01, 2023Center for Healthcare Policy and Research rolls out new weight loss and wellness initiative
A new “whole health” weight loss initiative launching at the UC Davis Health Folsom Clinic is based on a Center for Healthcare Policy and Research study.
Read More
February 2023
-
MIND InstituteFebruary 27, 2023
How does wildfire smoke impact pregnancy and children?
UC Davis researchers have been awarded $1.35 million from the Environmental Protection Agency to study the health impacts of wildfire smoke on pregnant people and children.
Read More -
Clinical ScienceFebruary 22, 2023Lipoprotein(a): A less understood but critical risk factor for heart disease
Endocrinology researchers are investigating non-genetic influences such as diet on lipoprotein(a) levels. Their study hopes to address gaps in knowledge around lipoprotein(a) and its effects on cardiovascular disease risk.
Read More -
ResearchFebruary 21, 2023UC Davis Health to develop in-utero therapy for Duchenne muscular dystrophy
Professor Aijun Wang won a $2 million grant from California’s Stem Cell Agency to develop a cure to Duchenne muscular dystrophy (DMD) using an in-utero gene editing formula.
Read More
